Trial · Mendelson et al., Frontiers in Nutrition(2023)
Kombucha tea as an anti-hyperglycemic agent in humans with diabetes—a randomized controlled pilot investigation(opens in a new tab)
- Findings and study population
- The randomized crossover used 240 mL/day for four weeks per drink, with eight-week washout. Glucose analysis involved seven people; the week-four between-drink p-value was .265. Trial kombucha contained 1.5% alcohol by volume.
- Limitations and differences from this claim
- Substantial missing data and a five-person subset limit inference; residual sugar was unmeasured. Drinks were donated and some authors disclosed interests in another microbial-products company. Other products and small portions remain untested.
Checked: